Developer docs
API playgroundTry for free, no card

Search company profiles

Boston Imaging Core Lab

Full company profile

uuid002cybj

Namestring
Boston Imaging Core Lab
Legal namestring
Boston Imaging Core Lab, LLC
Websiteurl
bicl.org
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Boston Imaging Core Lab, LLC (BICL) is a specialized clinical trial imaging core laboratory founded in June 2007 in Boston by three Academic Radiologists from Boston University School of Medicine. The company provides expert radiology image assessment services to pharmaceutical companies conducting clinical trials and to academic researchers running large musculoskeletal epidemiologic studies, with a flagship specialization in osteoarthritis and anti-nerve growth factor (aNGF) drug development.

BICL's core offering is human expert reading across six therapeutic areas: musculoskeletal imaging (with sub-focus on osteoarthritis, aNGF trials, and cartilage repair), neuroradiology, stroke, oncology and body imaging, pediatric imaging, and nuclear medicine and dosimetry. The technical platform combines clinical trial imaging using MRI, radiography, and nuclear medicine modalities with BICL's proprietary and co-developed semi-quantitative scoring systems (MOAKS, WORMS, BLOKS, KOSS, CROAKS, MOCART, RAMRIS) and complementary quantitative methods delivered through its 2009 partnership with Chondrometrics. BICL has cumulatively read over 30,000 time points from the NIH Osteoarthritis Initiative, 18,000+ from the Multicenter Osteoarthritis Study, and screened 23,079 patients across 480+ international sites in the Pfizer Tanezumab program, supported by 300+ peer-reviewed publications and a reader pool of 15 MSK academic radiologists including five full Professors of Radiology.

The business model is professional services on a project basis: quote-based enterprise contracts for clinical trial reading, eligibility screening, safety monitoring, and imaging protocol consulting, sold directly to pharmaceutical sponsors (Pfizer, Regeneron, Servier, Merck KGaA, Galapagos) and academic institutions, with secondary distribution through CRO partners (Clario, Calyx, Imaging Endpoints, Voiant Clinical) and imaging technology partners (Median Technologies, Keosys). Marketing is conducted primarily through scientific publications in Radiology, Osteoarthritis and Cartilage, and Seminars in Arthritis and Rheumatism, presentations at OARSI, ICRS, EULAR, and RSNA conferences, and engagement with FDA workshops on imaging biomarkers. An emerging AI/ML Support Services line provides expert annotations and clinical trial execution for third-party AI imaging products seeking FDA and EMA clearance.

Short descriptiontext

Boston Imaging Core Lab provides expert radiology imaging assessment for pharmaceutical clinical trials and academic research, with deep specialization in musculoskeletal and osteoarthritis imaging, serving pharma clients including Pfizer, Regeneron, Merck KGaA, Servier, and Galapagos.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial imaging, musculoskeletal radiology, osteoarthritis imaging, medical image assessment, imaging core lab
Industry2 codes
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAGAEAH
Imaging Core Labs & Clinical Endpoint Adjudication
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Imaging Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Imaging Services
TypeProfessional Services
Description

Professional image assessment services provided to pharmaceutical companies for clinical trials, including reading services by expert musculoskeletal radiologists, consulting on imaging protocols, and quality control supervision.

bicl.org
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Boston Imaging Core Lab (BICL) provides expert radiologist image assessment and consulting services for clinical trials and academic research. The lab specializes in musculoskeletal imaging (particularly osteoarthritis, anti-NGF studies, and cartilage repair) and extends services across neuroradiology, oncology and body imaging, pediatric imaging, nuclear medicine and dosimetry, stroke imaging, and AI/ML product validation for FDA and EMA clearance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 10.4% absolute gain in fracture detection sensitivity with AI assistance (64.8% to 75.2%)
+4 more records
Product overview1 text field

Boston Imaging Core Lab (BICL) is a specialized clinical trial imaging core laboratory offering expert radiology reading and consulting services. The core offering consists of imaging assessment services across six therapeutic areas: Musculoskeletal Imaging (with focus on osteoarthritis, NGF-inhibitor studies, and cartilage repair), Neuroradiology Imaging, Oncology & Body Imaging, Pediatric Imaging, Nuclear Medicine & Dosimetry, and Stroke Imaging. Supporting the core services are specialized semiquantitative and quantitative assessment instruments including MOAKS (MRI Osteoarthritis Knee Score) for OA assessment, CROAKS (Cartilage Repair Osteoarthritis Knee Score) for cartilage repair evaluation, MOCART for repair tissue assessment, RAMRIS for rheumatoid arthritis, DCE-MRI and dGEMRIC for composition imaging, and quantitative JSW measurement. BICL also provides AI/ML support services including expert annotations for FDA/EMA validation and clinical trial design for AI product validation. The company serves pharmaceutical industry clients and academic researchers through clinical trial imaging services and scientific expertise.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

BICL and Chondrometrics formed a partnership in 2009 to broaden and advance their capabilities for offering imaging biomarker analysis. Together they offer a comprehensive portfolio of imaging biomarkers including both quantitative (Chondrometrics) and semi-quantitative (BICL) approaches that provide complementary and synergistic information in clinical trials.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Clario provides clinical trial imaging services and partners with BICL for specialized musculoskeletal and osteoarthritis imaging reading services.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Calyx provides imaging services for clinical trials and partners with BICL for specialized radiology reading services.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Clinical trial imaging company that partners with BICL for specialized reading services.

5Voiant Clinical
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Clinical research services company that partners with BICL for specialized imaging reading capabilities.

bicl.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medical imaging company providing iCRO imaging services and AI-based image analysis for oncology clinical trials; directly comparable in trial-grade imaging reading and is a BICL channel partner.

TypeDirect peer
Description

Imaging core lab and clinical trial technology provider offering medical image management and central reading services; competes with BICL in central imaging reads for pharma trials and is listed as a BICL channel partner.

TypeEmerging player
Description

Quantitative cartilage, meniscus, and muscle MRI analysis provider partnered with BICL since 2009; closely comparable in MSK imaging biomarker services and shares joint go-to-market with BICL for OA trials.

TypeDirect peer
Description

Full-service clinical trial imaging and endpoint solutions provider offering central reading, image management, and cardiac safety; directly overlaps BICL's core lab services and is listed as a BICL channel partner.

TypeDirect peer
Description

Specialized clinical trial imaging core lab providing independent radiological review for oncology and other therapeutic areas; directly comparable to BICL as an independent imaging core lab serving pharma sponsors.

TypeDirect peer
Description

Imaging solution provider specializing in central imaging review and image management for clinical trials; directly overlaps BICL's core central reading services and is a BICL channel partner.

7Voiant Clinical
TypeDirect peer
Description

Clinical research services company with imaging reading capabilities for clinical trials; comparable to BICL in trial imaging reading and is a BICL channel partner.

TypeBroad incumbent
Description

Global CRO offering comprehensive clinical trial services including imaging and central reading; represents broad incumbent competition with full-service bundling that BICL cannot match independently.

TypeBroad incumbent
Description

Global CRO with imaging and central reading capabilities integrated into full-service clinical trial delivery; comparable on the imaging core lab dimension but with substantially broader scope and scale.

TypeEmerging player
Description

Quantitative imaging core lab specializing in biomarker-driven image analysis for clinical trials; comparable in trial imaging analysis and now integrated into Calyx's broader imaging platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Boston Imaging Core Lab

Clinical Trial Imaging Servicesbicl.org

Boston Imaging Core Lab provides expert radiology imaging assessment for pharmaceutical clinical trials and academic research, with deep specialization in musculoskeletal and osteoarthritis imaging, serving pharma clients including Pfizer, Regeneron, Merck KGaA, Servier, and Galapagos.

What Boston Imaging Core Lab does

Boston Imaging Core Lab, LLC (BICL) is a specialized clinical trial imaging core laboratory founded in June 2007 in Boston by three Academic Radiologists from Boston University School of Medicine. The company provides expert radiology image assessment services to pharmaceutical companies conducting clinical trials and to academic researchers running large musculoskeletal epidemiologic studies, with a flagship specialization in osteoarthritis and anti-nerve growth factor (aNGF) drug development.

BICL's core offering is human expert reading across six therapeutic areas: musculoskeletal imaging (with sub-focus on osteoarthritis, aNGF trials, and cartilage repair), neuroradiology, stroke, oncology and body imaging, pediatric imaging, and nuclear medicine and dosimetry. The technical platform combines clinical trial imaging using MRI, radiography, and nuclear medicine modalities with BICL's proprietary and co-developed semi-quantitative scoring systems (MOAKS, WORMS, BLOKS, KOSS, CROAKS, MOCART, RAMRIS) and complementary quantitative methods delivered through its 2009 partnership with Chondrometrics. BICL has cumulatively read over 30,000 time points from the NIH Osteoarthritis Initiative, 18,000+ from the Multicenter Osteoarthritis Study, and screened 23,079 patients across 480+ international sites in the Pfizer Tanezumab program, supported by 300+ peer-reviewed publications and a reader pool of 15 MSK academic radiologists including five full Professors of Radiology.

The business model is professional services on a project basis: quote-based enterprise contracts for clinical trial reading, eligibility screening, safety monitoring, and imaging protocol consulting, sold directly to pharmaceutical sponsors (Pfizer, Regeneron, Servier, Merck KGaA, Galapagos) and academic institutions, with secondary distribution through CRO partners (Clario, Calyx, Imaging Endpoints, Voiant Clinical) and imaging technology partners (Median Technologies, Keosys). Marketing is conducted primarily through scientific publications in Radiology, Osteoarthritis and Cartilage, and Seminars in Arthritis and Rheumatism, presentations at OARSI, ICRS, EULAR, and RSNA conferences, and engagement with FDA workshops on imaging biomarkers. An emerging AI/ML Support Services line provides expert annotations and clinical trial execution for third-party AI imaging products seeking FDA and EMA clearance.

Boston Imaging Core Lab firmographics

Firmographics
Name
Boston Imaging Core Lab
Legal name
Boston Imaging Core Lab, LLC
Website
https://bicl.org
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Boston Imaging Core Lab provides expert radiology imaging assessment for pharmaceutical clinical trials and academic research, with deep specialization in musculoskeletal and osteoarthritis imaging, serving pharma clients including Pfizer, Regeneron, Merck KGaA, Servier, and Galapagos.
Ownership category
akta.pro rank

Boston Imaging Core Lab industry classification

Industry
Product category
Clinical Trial Imaging Services
NAICS
Medical Laboratories (621511)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAGAEAH
Imaging Core Labs & Clinical Endpoint Adjudication
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical trial imaging
  • Musculoskeletal radiology
  • Osteoarthritis imaging
  • Medical image assessment
  • Imaging core lab

Where Boston Imaging Core Lab is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Boston Imaging Core Lab business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Imaging Services: Professional image assessment services provided to pharmaceutical companies for clinical trials, including reading services by expert musculoskeletal radiologists, consulting on imaging protocols, and quality control supervision.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Boston Imaging Core Lab product offering

Product offering

Core offering

Boston Imaging Core Lab (BICL) provides expert radiologist image assessment and consulting services for clinical trials and academic research. The lab specializes in musculoskeletal imaging (particularly osteoarthritis, anti-NGF studies, and cartilage repair) and extends services across neuroradiology, oncology and body imaging, pediatric imaging, nuclear medicine and dosimetry, stroke imaging, and AI/ML product validation for FDA and EMA clearance.

Product overview

Boston Imaging Core Lab (BICL) is a specialized clinical trial imaging core laboratory offering expert radiology reading and consulting services. The core offering consists of imaging assessment services across six therapeutic areas: Musculoskeletal Imaging (with focus on osteoarthritis, NGF-inhibitor studies, and cartilage repair), Neuroradiology Imaging, Oncology & Body Imaging, Pediatric Imaging, Nuclear Medicine & Dosimetry, and Stroke Imaging. Supporting the core services are specialized semiquantitative and quantitative assessment instruments including MOAKS (MRI Osteoarthritis Knee Score) for OA assessment, CROAKS (Cartilage Repair Osteoarthritis Knee Score) for cartilage repair evaluation, MOCART for repair tissue assessment, RAMRIS for rheumatoid arthritis, DCE-MRI and dGEMRIC for composition imaging, and quantitative JSW measurement. BICL also provides AI/ML support services including expert annotations for FDA/EMA validation and clinical trial design for AI product validation. The company serves pharmaceutical industry clients and academic researchers through clinical trial imaging services and scientific expertise.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 10.4% absolute gain in fracture detection sensitivity with AI assistance (64.8% to 75.2%)
  • +4 more outcomes

Companies that use Boston Imaging Core Lab

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Boston Imaging Core Lab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Boston Imaging Core Lab partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • ChondrometricscoreStrategic or Co-development Partner · 1 January 2009BICL and Chondrometrics formed a partnership in 2009 to broaden and advance their capabilities for offering imaging biomarker analysis. Together they offer a comprehensive portfolio of imaging biomarkers including both quantitative (Chondrometrics) and semi-quantitative (BICL) approaches that provide complementary and synergistic information in clinical trials.
  • ClariominorChannel Partner/ Reseller/ DistributorClario provides clinical trial imaging services and partners with BICL for specialized musculoskeletal and osteoarthritis imaging reading services.
  • CalyxminorChannel Partner/ Reseller/ DistributorCalyx provides imaging services for clinical trials and partners with BICL for specialized radiology reading services.
  • Imaging EndpointsminorChannel Partner/ Reseller/ DistributorClinical trial imaging company that partners with BICL for specialized reading services.
  • Voiant ClinicalminorChannel Partner/ Reseller/ DistributorClinical research services company that partners with BICL for specialized imaging reading capabilities.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Boston Imaging Core Lab competitors and assessment

Company assessment

Direct peers

  • Median Technologies: Medical imaging company providing iCRO imaging services and AI-based image analysis for oncology clinical trials; directly comparable in trial-grade imaging reading and is a BICL channel partner.
  • Calyx: Imaging core lab and clinical trial technology provider offering medical image management and central reading services; competes with BICL in central imaging reads for pharma trials and is listed as a BICL channel partner.
  • Clario (formerly BioClinica): Full-service clinical trial imaging and endpoint solutions provider offering central reading, image management, and cardiac safety; directly overlaps BICL's core lab services and is listed as a BICL channel partner.
  • Imaging Endpoints: Specialized clinical trial imaging core lab providing independent radiological review for oncology and other therapeutic areas; directly comparable to BICL as an independent imaging core lab serving pharma sponsors.
  • Keosys: Imaging solution provider specializing in central imaging review and image management for clinical trials; directly overlaps BICL's core central reading services and is a BICL channel partner.
  • Voiant Clinical: Clinical research services company with imaging reading capabilities for clinical trials; comparable to BICL in trial imaging reading and is a BICL channel partner.

Emerging players

  • Chondrometrics: Quantitative cartilage, meniscus, and muscle MRI analysis provider partnered with BICL since 2009; closely comparable in MSK imaging biomarker services and shares joint go-to-market with BICL for OA trials.
  • VirtualScopics (now part of Calyx): Quantitative imaging core lab specializing in biomarker-driven image analysis for clinical trials; comparable in trial imaging analysis and now integrated into Calyx's broader imaging platform.

Broad incumbents

  • ICON plc: Global CRO offering comprehensive clinical trial services including imaging and central reading; represents broad incumbent competition with full-service bundling that BICL cannot match independently.
  • Parexel: Global CRO with imaging and central reading capabilities integrated into full-service clinical trial delivery; comparable on the imaging core lab dimension but with substantially broader scope and scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Boston Imaging Core Lab social profiles

Digital presence

Boston Imaging Core Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Boston Imaging Core Lab leadership team

Management profile

Number of profiles

Profiles3 records

Boston Imaging Core Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Boston Imaging Core Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Imaging Core Lab

What does Boston Imaging Core Lab do?

Boston Imaging Core Lab (BICL) provides expert radiologist image assessment and consulting services for clinical trials and academic research. The lab specializes in musculoskeletal imaging (particularly osteoarthritis, anti-NGF studies, and cartilage repair) and extends services across neuroradiology, oncology and body imaging, pediatric imaging, nuclear medicine and dosimetry, stroke imaging, and AI/ML product validation for FDA and EMA clearance.

Is Boston Imaging Core Lab a public or private company?

Boston Imaging Core Lab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Boston Imaging Core Lab founded?

Boston Imaging Core Lab was founded in 2007. It employs 1 to 10 people.

Where is Boston Imaging Core Lab based?

Boston Imaging Core Lab is headquartered in Boston, United States, in the North America region.

How does Boston Imaging Core Lab make money?

One revenue line is on record: clinical Trial Imaging Services.

Who are Boston Imaging Core Lab's main competitors?

Direct peers on record are Median Technologies, Calyx, Clario (formerly BioClinica), Imaging Endpoints, Keosys and Voiant Clinical. Emerging players are Chondrometrics and VirtualScopics (now part of Calyx). Broad incumbents are ICON plc and Parexel.

Does Boston Imaging Core Lab have an API?

No public API is recorded for Boston Imaging Core Lab.

What industry is Boston Imaging Core Lab in?

Boston Imaging Core Lab's product category is Clinical Trial Imaging Services. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG), with a secondary code of HLAGAEAH, Imaging Core Labs & Clinical Endpoint Adjudication. Its NAICS code is 621511 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales